ClinicalTrials.Veeva

Menu

Access to Kidney Transplant of Obese Patients Beginning Dialysis (Transplantob)

C

Centre Hospitalier Universitaire, Amiens

Status

Enrolling

Conditions

Kidney Transplant Access
Dialysis
Comorbidities
Obese Patients

Study type

Observational

Funder types

Other

Identifiers

NCT04748770
PI2021_843_0016

Details and patient eligibility

About

Obesity is in constant increase all over the world and affects 35% of the global population according to the World Health Organisation. It is associated with other cardiovascular risk factors (particularly hypertension and diabetes) and with high morbi-mortality. It is also responsible for an increase of the risk of developing chronic kidney diseases (CKD). In fact, obese patients represent 25% of the dialysis population and Picardy is one of the most affected areas. However, their access to kidney transplant is still restricted and the reasons are not completely understood.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age over 18 years old.
  • Patients with BMI≥30 kg/m2 (for study population) and 25≤BMI≤30 kg/m2(for control population) one month after dialysis initiation.
  • Patients agree with their data collection.

Exclusion criteria

  • Patients with bariatric surgery history.
  • Patients needed dialysis for graft dysfunction.
  • Data loss.

Trial design

100 participants in 2 patient groups

patients with BMI≥30 kg/m2
patients with 25≤BMI≤30 kg/m2

Trial contacts and locations

1

Loading...

Central trial contact

Pauline Caillard, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems